A

Arvinas

399 employees

Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.

Investor insights

Sectors invested in

Biotechnology1

Funding rounds participated in

$55M sweet spot round size

Most of their 1 investments are in rounds between $55M and $55M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceutical

Date founded

2013

Investments made

O

Oerth Bio raised $55M on February 27, 2020

Investors: Arvinas

Funding rounds raised

Total raised

$55M

from 16 investors over 16 rounds

A

Arvinas raised $55M on April 4, 2018

Investors: Nextech Invest, 5AM Ventures, New Leaf Venture Partners, OrbiMed Advisors, Hillhouse Capital Management, Canaan, RA Capital Management, L.P. and Sirona Capital

A

Arvinas raised $42M on October 21, 2015

Investors: 5AM Ventures, Canaan, OrbiMed Advisors, New Leaf Venture Partners and RA Capital Management, L.P.

A

Arvinas raised $15M on September 26, 2013

Investors: Canaan, 5AM Ventures and Elm Street Ventures

FAQ